[Watchlist](6/28 - 7/4/20) <$CREX $FLIR $MARK $FRSX $XSPA $AHPI $APT $NBY $MMM $IDEX $KTOV $CHK $OBSV $NVAX $ZYNE $ITRM $CERC $INO>

[Disclaimer]:  I am not a professional, I expect you to do your own research and due diligence on any investment or trade that you may perform.  None of the following is financial advice in any way shape or form.  Trade at your own risk.

 

My focus this week is on safety plays as COVID 19 fears continue to rapidly rise, mask plays from Pence's conference recommending mandatory mask usage, and then my usual run of Biotech mayhem which just happens to have a very big week ahead of us.

 

<$MARK Remark Holdings Inc (NASDAQ: MARK) (Current Price: $2.22) (Float: 93.548M):> Remark Holdings Inc delivers an integrated suite of AI solutions that enable businesses and organizations to solve problems, reduce risk and deliver positive outcomes. The company's easy-to-install AI products are being rolled out in a range of applications within the retail, financial, public safety, and workplace arenas. The company also owns and operates digital media properties that deliver relevant content and e-commerce solutions. The group operates in one segment namely Technology & Data Intelligence segment which provides products and services to customers based upon the data collected and processed by its proprietary data intelligence software.

+ Remark is in a really special place right now, they are set to be one of the possible companies to take full advantage of the world's economy needing to recover from COVID 19, forever changed, safety is a priority with thermal screening and immediate testing in high traffic and many businesses so that people feel safe to be there.

+ Remark also has highly anticipated Q1 earnings set to release on Monday July 6th after the close, no estimations have been released at this time, which could change a lot for my perspective, but I expect a speedy runup this short 4-day week and again Monday July 6th leading into the earnings release.

<CHART or SWING TRADE>

Below are some other tickers I expect to have positive weeks ahead based on safety needed in place.

<$CREX Creative Realities Inc (NASDAQ: CREX) (Current Price: $2.61) (Float: 4.744M):>

<$FLIR FLIR Systems Inc (NASDAQ: FLIR) (Current Price: $39.07) (Float: 114.837M):>

<$FRSX Foresight Autonomous Holdings Inc (NASDAQ: FRSX) (Current Price: $1.64) (Float: 30Mish):>

<$XSPA XpresSpa Group Inc (NASDAQ: XSPA) (Current Price: $4.03) (Float: 48.848M):>

  

Another interesting thing that happened this weekend is that Vice President Pence strongly suggested mandatory masks be worn at all times.  https://www.nbcnews.com/politics/donald-trump/contrast-trump-pence-encourages-wearing-masks-prevent-coronavirus-spread-n1232368

Because of this, I expect the following tickers to get some positive uptrending this week.

<$APT Alpha Pro Tech Ltd (AMEX: APT) (Current Price: $17.49) (Float: 12.274M):>

<$AHPI Allied Healthcare Products Inc (NASDAQ: AHPI) (Current Price: $11.43) (Float: 2.227M):>

<$NBY Novabay Pharmaceuticals (AMEX: NBY) (Current Price: $1.13) (Float: 18.249M):>

 

<$IDEX Ideanomics Inc (NASDAQ: IDEX) (Current Price: $1.39) (Float: 137.778M):> Ideanomics Inc is a global company focused on facilitating the adoption of commercial electric vehicles and developing next-generation financial services and Fintech products. Its electric vehicle division, Mobile Energy Global (MEG) provides group purchasing discounts on commercial electric vehicles, EV batteries and electricity as well as financing and charging solutions. Ideanomics Capital includes DBOT ATS and Intelligenta which provide financial services solutions powered by AI and blockchain. Geographically, the company generates a majority of its revenue from the United States.

+ Last week was crazy for Ideanomics, they had a serious uptrend as expected until HindenburgRes, a short selling fund, released a lot of information detailing $IDEX as a fraud.  This tanked the stock down to its current value.

+ Over the weekend Ideanomics themselves fought back, releasing a video and other information confirming they are in fact not a fraud and in very good shape.  Take this for what you will however.  This has been circulated a lot on twitter.

I'm looking for a nice spike up off the weekends rebuttal with a very nice downside short following as bagholders unload their shares.

<CHART TRADE>

 

<$KTOV Kitov Pharma Ltd (NASDAQ: KTOV) (Current Price: $1.21) (Float: 75Mish):> Kitov Pharma Ltd is a development stage biopharmaceutical company. It focuses on the development of KIT-302, a combination drug for the simultaneous treatment of two clinical conditions pain caused by osteoarthritis and hypertension; and NT219 which is a fixed-dose combination of two drug products that treat osteoarthritis pain and hypertension simultaneously. The company's operating segment include Pain and Hypertension and Oncology, It generates maximum revenue from the Pain and Hypertension segment.

+ Rumors of the Merck ($MRK) and Kitov deal flying high on twitter this weekend, I expect a continued uptrend for $KTOV.  Remember though buy the rumor, sell the news.

+ For what its worth, not much mind you other than his massive following of sheoples, David Portnoy is also in on $KTOV as of this weekend.

<CHART or SWING TRADE>

 

<$CHK Chesapeake Energy Corp (NYSE: CHK) (Current Price: $11.61) (Float: 9.783M):> $CHK started the process of bankruptcy this weekend, this has been long expected to happen so keep that in mind.  That being said the bankruptcy sector is seriously hot right now and this has the float to move.  Play the price action accordingly.

<CHART TRADE>

 

<$OBSV ObsEva Sa (NASDAQ: OBSV) (Current Price: $5.71) (Float: 31.716M):> ObsEva SA is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy. The company is focused on providing therapeutic solutions for women between the ages of 15 and 49 who suffer from reproductive health conditions that affect their quality of life, ability to conceive or that complicate pregnancy and the health of newborns. The is developing OBE2109 as a novel, oral gonadotropin-releasing hormone, or GnRH, receptor antagonist, for the treatment of pain associated with endometriosis and heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women.

+ ObsEva is set to release Phase 3 PRIMROSE 1, 6-month primary endpoint results and PRIMROSE 2 twelve-month data for Linzagolix in uterine fibroids.

Watch for uptrending leading into the news which I believe will be released Tuesday, then depending on the results, watch out. UPDATE Conference Call Scheduled Monday July 6th at 8am to discuss results, exepct a nice runup to this call

<CHART or SWING TRADE>

 

<$NVAX Novavax Inc (NASDAQ: NVAX) (Current Price: $75.5) (Float: 58.444M):>

+ Novavax is scheduled to release top-line data from Matrix M vaccine adjuvant, which is a key component of Serum Institute of India's malaria vaccine candidate.  I believe this release will be on Tuesday.  Expecting positive results, $NVAX to me however is overextended at this time.

<CHART OR SWING TRADE>

 

<$ZYNE Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE) (Current Price: $6.34) (Float: 21.619M):> Zynerba Pharmaceuticals Inc together with its subsidiary is a pharmaceutical company which is focused on developing and commercializing proprietary next generation synthetic cannabinoid therapeutics formulated for transdermal delivery. Its product candidates are ZYN001 and ZYN002. The company has initiated a clinical trial for both the product candidates.

+ Zynerba is expected to release topline data from the pivotal CONNECT-FX trial that is evaluating Zygel in Fragile X syndrome.

+ Zynerba had very positive results last time, and I expect the same again.

<$CHART or SWING TRADE>

 

<$ITRM Iterum Therapeutics PLC (NASDAQ: ITRM) (Current Price: $1.53) (Float: 5.968M):> Iterum Therapeutics PLC is a pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally. Its sulopenem program has the potential to offer a solution to the problem of antibiotic resistance and the toxicity limitations of existing agents.

+ Iterum is due to release Phase 3 topline results from sulopenem clinical trials in uncomplicated urinary tract infections.

Nice low price, low float, phase 3 results, I expect some action here one way or the other.

<CHART TRADE>

 

<$CERC Cerecor Inc (NASDAQ: CERC) (Current Price: $2.41) (Float: 29.722M):> Cerecor Inc is a biopharmaceutical company with commercial operations and research and development capabilities. The Company is building a robust pipeline of innovative therapies in neurology, pediatric healthcare, and orphan rare diseases. The Company is also developing three other neurological clinical and preclinical stage compounds. The Company's pediatric orphan rare disease pipeline is led by CERC-801, CERC-802 and CERC-803. The Company also markets prescription drugs that treat a range of pediatric diseases, disorders and conditions. Cerecor's prescription drugs include Millipred, Ulesfia, Karbinal ER, AcipHex Sprinkle and Cefaclor for Oral Suspension. The Company has marketed medical device, Flexichamber.

+ Cerecor is due to release initial data readout from the Phase 1 trial of CERC-802 in healthy volunteers.

<CHART TRADE>

 

<$INO Inovio Pharmaceuticals Inc (NASDAQ: INO) (Current Price: $28.56) (Float: 154.690M):> Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.

+ Inovio will release interim Phase 1 data for its coronavirus vaccine candidate INO-4800.

+ After Inovio's DOD contract news last week I expect good news from the coronavirus vaccine report, very big news here could make or break $INO. 

<CHART or SWING TRADE>